価格表
在庫・価格 : 2024年06月03日 06時03分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-SARS-CoV-2 (COVID-19) nucleocapsid, Rabbit-Mono(HL344) データシート |
GTX635679 |
GNTジーンテックス GeneTex International Corporation |
25 μl | ¥24,000 |
無 (未発注) |
追加 |
在庫・価格 : 2024年06月03日 06時03分 現在
使用文献
- No.: 2
-
文献情報:
Ruetalo N et al. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients. mSphere 2021 02;6(1)
Ruetalo N et al
2021/01/01
-
備考:
-
参照:
- No.: 3
-
文献情報:
Song E et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021 03;218(3)
Song E et al
2021/01/01
-
備考:
-
参照:
- No.: 4
-
文献情報:
Heaton BE et al. SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2. bioRxiv 2020 Aug;
Heaton BE et al
2020/01/01
-
備考:
-
参照:
- No.: 5
-
文献情報:
Ramani A et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J 2020 10;39(20):e106230
Ramani A et al
2020/01/01
-
備考:
-
参照:
- No.: 7
-
文献情報:
Song E et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. bioRxiv 2020 Sep;
Song E et al
2020/01/01
-
備考:
-
参照:
- No.: 8
-
文献情報:
Sasaki M et al. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. mBio 2021 08;12(4):e0141521
Sasaki M et al
2021/01/01
-
備考:
-
参照:
- No.: 9
-
文献情報:
Sacco MD et al. Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M<sup>pro</sup> and cathepsin L. bioRxiv 2020 Jul;
Sacco MD et al
2020/01/01
-
備考:
-
参照:
- No.: 10
-
文献情報:
. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol 2021 05;6(59)
2021/01/01
-
備考:
-
参照:
- No.: 11
-
文献情報:
Garc鱈a-Dorival I et al. Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target. Antiviral Res 2021 10;194:105167
Garc鱈a-Dorival I et al
2021/01/01
-
備考:
-
参照:
- No.: 12
-
文献情報:
Asaka MN et al. Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. JCI Insight 2021 10;6(19)
Asaka MN et al
2021/01/01
-
備考:
-
参照:
- No.: 13
-
文献情報:
Tsuji K et al. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing. J Toxicol Sci 2021;46(9):425-435
Tsuji K et al
2021/01/01
-
備考:
-
参照:
- No.: 14
-
文献情報:
Meng B et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature 2022 Feb;
Meng B et al
2022/01/01
-
備考:
-
参照:
- No.: 15
-
文献情報:
Suzuki R et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 2022 Feb;
Suzuki R et al
2022/01/01
-
備考:
-
参照:
- No.: 16
-
文献情報:
Wright T et al. Photodynamic and Contact Killing Polymeric Fabric Coating for Bacteria and SARS-CoV-2. ACS Appl Mater Interfaces 2022 Jan;14(1):49-56
Wright T et al
2022/01/01
-
備考:
-
参照:
- No.: 17
-
文献情報:
Jiang W et al. A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge. Cell Rep 2021 12;37(11):110112
Jiang W et al
2021/01/01
-
備考:
-
参照:
- No.: 18
-
文献情報:
Conforti A et al. COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models. Mol Ther 2022 01;30(1):311-326
Conforti A et al
2022/01/01
-
備考:
-
参照:
- No.: 19
-
文献情報:
Ohno M et al. Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2. Viruses 2021 10;13(11)
Ohno M et al
2021/01/01
-
備考:
-
参照:
- No.: 20
-
文献情報:
Sacco MD et al. Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M<sup>pro</sup> and cathepsin L. Sci Adv 2020 12;6(50)
Sacco MD et al
2020/01/01
-
備考:
-
参照:
- No.: 21
-
文献情報:
Yasui F et al. Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice. Sci Rep 2022 Mar;12(1):4150
Yasui F et al
2022/01/01
-
備考:
-
参照:
- No.: 22
-
文献情報:
Seifert M et al. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. Elife 2021 Oct;10
Seifert M et al
2021/01/01
-
備考:
-
参照:
- No.: 23
-
文献情報:
Ma C et al. Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay. ACS Cent Sci 2021 Jul;7(7):1245-1260
Ma C et al
2021/01/01
-
備考:
-
参照:
- No.: 24
-
文献情報:
Argueta LB et al. SARS-CoV-2 Infects Syncytiotrophoblast and Activates Inflammatory Responses in the Placenta. bioRxiv 2021 Jun;
Argueta LB et al
2021/01/01
-
備考:
-
参照:
- No.: 25
-
文献情報:
Ma H et al. Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain. J Virol 2021 Mar;95(10)
Ma H et al
2021/01/01
-
備考:
-
参照:
- No.: 26
-
文献情報:
Gupta R. SARS-CoV-2 Omicron spike mediated immune escape and tropism shift. Res Sq 2022 Jan;
Gupta R
2022/01/01
-
備考:
-
参照:
- No.: 27
-
文献情報:
Kitamura N et al. Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors. J Med Chem 2022 Feb;65(4):2848-2865
Kitamura N et al
2022/01/01
-
備考:
-
参照:
- No.: 28
-
文献情報:
Argueta LB et al. Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy. iScience 2022 May;25(5):104223
Argueta LB et al
2022/01/01
-
備考:
-
参照:
- No.: 29
-
文献情報:
Shapira T et al. A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature 2022 May;605(7909):340-348
Shapira T et al
2022/01/01
-
備考:
-
参照:
- No.: 30
-
文献情報:
Imbiakha B et al. Adaptive immune cells are necessary for SARS-CoV-2-induced pathology. Sci Adv 2024 Jan;10(1):eadg5461
Imbiakha B et al
2024/01/01
-
備考:
-
参照:
- No.: 31
-
文献情報:
Zhang L et al. CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation. mBio 2024 Feb;15(2):e0307123
Zhang L et al
2024/01/01
-
備考:
-
参照:
- No.: 32
-
文献情報:
Tsumita T et al. Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models. Aging Cell 2024 Feb;23(2):e14050
Tsumita T et al
2024/01/01
-
備考:
-
参照:
- No.: 33
-
文献情報:
Castro V et al. Three-Dimensional Remodeling of SARS-CoV2-Infected Cells Revealed by Cryogenic Soft X-ray Tomography. ACS Nano 2023 Nov;17(22):22708-22721
Castro V et al
2023/01/01
-
備考:
-
参照:
- No.: 34
-
文献情報:
Uemura K et al. 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses. Proc Natl Acad Sci U S A 2023 Oct;120(42):e2304139120
Uemura K et al
2023/01/01
-
備考:
-
参照:
- No.: 35
-
文献情報:
Imbiakha B et al. Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5. Sci Adv 2023 Sep;9(38):eadj1736
Imbiakha B et al
2023/01/01
-
備考:
-
参照:
- No.: 36
-
文献情報:
P辿rez-Vargas J et al. A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants. Emerg Microbes Infect 2023 Dec;12(2):2246594
P辿rez-Vargas J et al
2023/01/01
-
備考:
-
参照:
- No.: 37
-
文献情報:
Andreu S et al. Dextran sulfate from <i>Leuconostoc mesenteroides</i> B512F exerts potent antiviral activity against SARS-CoV-2 <i>in vitro</i> and <i>in vivo</i>. Front Microbiol 2023;14:1185504
Andreu S et al
2023/01/01
-
備考:
-
参照:
- No.: 38
-
文献情報:
Cloherty APM et al. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade. Emerg Microbes Infect 2023 Dec;12(1):2195020
Cloherty APM et al
2023/01/01
-
備考:
-
参照:
- No.: 39
-
文献情報:
Li Z et al. The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation. Signal Transduct Target Ther 2023 Feb;8(1):53
Li Z et al
2023/01/01
-
備考:
-
参照:
- No.: 40
-
文献情報:
Garcia G et al. Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response. PLoS Biol 2022 Nov;20(11):e3001851
Garcia G et al
2022/01/01
-
備考:
-
参照:
- No.: 41
-
文献情報:
Gon巽alves R et al. SARS-CoV-2 variants induce distinct disease and impact in the bone marrow and thymus of mice. iScience 2023 Feb;26(2):105972
Gon巽alves R et al
2023/01/01
-
備考:
-
参照:
- No.: 42
-
文献情報:
Shapira T et al. Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication. Mol Biomed 2022 Dec;3(1):43
Shapira T et al
2022/01/01
-
備考:
-
参照:
- No.: 43
-
文献情報:
P辿rez-Vargas J et al. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics. Antiviral Res 2023 Jan;209:105484
P辿rez-Vargas J et al
2023/01/01
-
備考:
-
参照:
- No.: 44
-
文献情報:
Yaron TM et al. Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication. Sci Signal 2022 Oct;15(757):eabm0808
Yaron TM et al
2022/01/01
-
備考:
-
参照:
- No.: 45
-
文献情報:
Shimizu H et al. LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19. iScience 2022 Nov;25(11):105314
Shimizu H et al
2022/01/01
-
備考:
-
参照:
- No.: 46
-
文献情報:
Yamamoto Y et al. Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid. Int J Mol Sci 2022 Dec;24(1)
Yamamoto Y et al
2022/01/01
-
備考:
-
参照:
- No.: 47
-
文献情報:
Yamamoto Y et al. SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. Int J Mol Sci 2022 Dec;23(24)
Yamamoto Y et al
2022/01/01
-
備考:
-
参照: